Healthcare Press

FDA grants priority review for over-the-counter naloxone nasal spray to treat opioid overdose

  • 📰 KSLcom
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Contract drugmaker Emergent Biosolutions said its over-the-counter nasal spray as a treatment for suspected opioid overdose would be reviewed on a priority basis by the FDA.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 549. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. FDA to review Emergent's OTC opioid overdose drug on priorityContract drugmaker Emergent Biosolutions said on Tuesday its over-the-counter nasal spray as a treatment for suspected opioid overdose would be reviewed on a priority basis by the U.S. health regulator.
Source: Reuters - 🏆 2. / 97 Read more »